Melatonin for acute central serous chorioretinopathy
Treatments studied
Part of Eyes & vision clinical trials.
This trial tests whether taking oral melatonin can help people with acute central serous chorioretinopathy, a condition where fluid builds up under the retina and causes blurred vision. If effective, this simple treatment might help improve vision and speed up recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You were diagnosed with central serous chorioretinopathy within the past 6 weeks
- You have not had vitrectomy surgery or laser surgery on the affected eye in the last 3 months
- You have not received anti-VEGF injections in the affected eye in the last 3 months
- You are not pregnant or nursing
- You are not taking part in any other investigational drug study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a gentle laser treatment called micropulse laser for people with chronic central serous chorioretinopathy. It aims to help dry up the fluid under the retina that has not responded to standard medications for at least 6 months.
This study tests whether mindfulness practices can help people with central serous chorioretinopathy, a condition where fluid builds up under the retina and blurs vision. It aims to see if mindfulness reduces stress and improves recovery compared to usual care.
This study looks at the link between gut bacteria and central serous chorioretinopathy (CSC), a condition where fluid builds up under the retina. It may help us understand why some people get CSC and find better ways to treat it.
This trial studies rare diseases affecting the retina or choroid using detailed eye scans (OCT). It may help doctors better understand how these conditions look in the eye and how imaging findings relate to vision.
This Phase 2 study tests whether melatonin can improve sleep and possibly outcomes related to diabetic retinopathy (damage to the retina from diabetes). It also checks whether it affects related symptoms while keeping people safe.
This Phase 3 study tests whether taking melatonin after treatment for uveal melanoma can reduce the chance that the cancer returns or spreads to other parts of the body. It is aimed at people with higher-risk eye melanoma features.
Hear when a new Central Serous Chorioretinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.